Recent APAC MRDR presentations!
The APAC MRDR Coordinating Principal Investigator, Professor Andrew Spencer, recently presented an oral presentation at Blood 2025, titled Regional trends…
Milestone Achieved: APAC MRDR Reaches 3,000 participants with Hospital Support
The APAC MRDR has recently enrolled its 3,000th patient, marking a step towards improving understanding and treatment of myeloma across…
APAC MRDR Open Meeting 2025
APAC MRDR was pleased to host the annual Open Meeting 2025 in August! The virtual meeting was a great opportunity…
Two Recent APAC MRDR Abstract Presentations!
Congratulations to A/Prof Jihyun Lee for her recent oral presentation titled “Toxicity-related treatment cessation in newly diagnosed multiple myeloma –…
Welcome to our new Malaysian sites
In October the APAC MRDR welcomed three new sites from Malaysia. Ampang Hospital, Hospital Pulau Pinang (Penang General Hospital) and…
APAC MRDR Investigators’ Meeting – 2022 Recording
Missed the APAC MRDR Investigators’ Meeting for 2022? Watch the presentation below with talks from Professor Andrew Spencer, Dr Justin…
APAC MRDR Investigators’ Meeting 2022
We are pleased to invite you to our APAC MRDR Investigators’ Meeting at the 19th International Myeloma Society (IMS) Annual…
APAC MRDR Investigators’ Meeting 2021 – video
Missed the APAC MRDR Investigators’ Meeting in 2021? Watch the first presentation below where Professor Andrew Spencer provides an overview…
1000 Study Participants registered!
The APAC MRDR has reached a significant milestone with 1000 study participants registered from Korea, Singapore, Malaysia and Taiwan. A…
RARE DISEASE DAY 2022
Monday 28 February is Rare Disease Day. Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity…
